Research Directory

Developing biosimilar monoclonal antibodies will not be easy

Read more

Gene therapy: a history and appraisal

Read more

Oxford BioMedica perfects lentiviral vectors for gene therapy

Read more

Symphogen sees opportunities in antibody mixtures

Read more

Capital efficiency -- a new norm

Read more

A small molecule approach to inflammation: Chroma Therapeutics targets the macrophage

Read more

Securing Europe's lead in vaccine research

Read more

Review of oncology in 2010

Read more

2011: A year of optimism and trepidation

Read more

ArGEN-X builds a new antibody business

Read more